{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:26:59Z","timestamp":1774330019814,"version":"3.50.1"},"reference-count":214,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013099","name":"Scientific Research Fund of Liaoning Provincial Education Department","doi-asserted-by":"publisher","award":["LJKMZ20221167"],"award-info":[{"award-number":["LJKMZ20221167"]}],"id":[{"id":"10.13039\/501100013099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbadis.2025.167676","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:33:03Z","timestamp":1737142383000},"page":"167676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies"],"prefix":"10.1016","volume":"1871","author":[{"given":"Shuairan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167676_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2025.167676_bb0010","doi-asserted-by":"crossref","unstructured":"Rumgay, H. et al. Global, regional and national burden of primary liver cancer by subtype. European journal of cancer (Oxford, England: 1990) 161, 108\u2013118, doi:https:\/\/doi.org\/10.1016\/j.ejca.2021.11.023 (2022).","DOI":"10.1016\/j.ejca.2021.11.023"},{"key":"10.1016\/j.bbadis.2025.167676_bb0015","article-title":"Global burden of disease study","volume":"2024","author":"Tan","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gendis.2021.09.006","article-title":"Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies","volume":"10","author":"Liu","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0035","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167676_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.copbio.2016.02.007","article-title":"Impact of the physical microenvironment on tumor progression and metastasis","volume":"40","author":"Spill","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2013.tb00510.x","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0070","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2008-12-172825","article-title":"Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB","volume":"113","author":"Hagemann","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.167676_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"Giraldo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/s12276-023-01068-z","article-title":"A new era of macrophage-based cell therapy","volume":"55","author":"Na","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0090","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/hep.26754","article-title":"Macrophage plasticity and polarization in liver homeostasis and pathology","volume":"59","author":"Sica","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41419-024-06888-z","article-title":"Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0105","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167676_bb0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167676_bb0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0120","doi-asserted-by":"crossref","first-page":"1601479","DOI":"10.1080\/2162402X.2019.1601479","article-title":"SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC","volume":"8","author":"Yin","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0125","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.24599","article-title":"An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice","volume":"54","author":"Mandrekar","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41423-019-0315-0","article-title":"Epigenetic regulation of macrophages: from homeostasis maintenance to host defense","volume":"17","author":"Chen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1872-034X.2012.01088.x","article-title":"Role of gut microbiota in liver diseases","volume":"43","author":"Miyake","year":"2013","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhep.2012.06.011","article-title":"Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats","volume":"57","author":"Zhang","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0145","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/ncomms16017","article-title":"YAP determines the cell fate of injured mouse hepatocytes in vivo","volume":"8","author":"Miyamura","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.167676_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep4.1494","article-title":"Multispectral imaging enables characterization of intrahepatic macrophages in patients with chronic liver disease","volume":"4","author":"Saldarriaga","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bbadis.2025.167676_bb0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.immuni.2016.12.001","article-title":"The heterogeneity of Ly6C(hi) monocytes controls their differentiation into iNOS(+) macrophages or monocyte-derived dendritic cells","volume":"45","author":"Menezes","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167676_bb0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/HEP.0000000000000524","article-title":"Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-\u03b1 in patients with chronic hepatitis B","volume":"79","author":"Jiang","year":"2024","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0175","doi-asserted-by":"crossref","unstructured":"Watkins, S. K., Egilmez, N. K., Suttles, J. & Stout, R. D. IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. Journal of immunology (Baltimore, Md.: 1950) 178, 1357\u20131362, doi:https:\/\/doi.org\/10.4049\/jimmunol.178.3.1357 (2007).","DOI":"10.4049\/jimmunol.178.3.1357"},{"key":"10.1016\/j.bbadis.2025.167676_bb0180","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0185","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic regulation of macrophage polarization in Cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0190","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-005-0703-4","article-title":"Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression","volume":"54","author":"Sinha","year":"2005","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.bbadis.2025.167676_bb0195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","article-title":"Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease","volume":"31","author":"Van Dyken","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbadis.2025.167676_bb0205","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1038\/s41598-017-14709-x","article-title":"Precision targeting of tumor macrophages with a CD206 binding peptide","volume":"7","author":"Scodeller","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167676_bb0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.167676_bb0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"Ruffell","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","volume":"2015","author":"R\u0151szer","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbadis.2025.167676_bb0225","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167676_bb0230","doi-asserted-by":"crossref","first-page":"34342","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167676_bb0235","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev-immunol-101320-031931","article-title":"Spatiotemporal adaptations of macrophage and dendritic cell development and function","volume":"40","author":"Roquilly","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105576","article-title":"A sweet spot for macrophages: focusing on polarization","volume":"167","author":"Yang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1221557","article-title":"Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1\u03b1induced IL-10","volume":"5","author":"Ambade","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0250","series-title":"The Cellular and Molecular Origin of Tumor-Associated Macrophages. Science (New York, N.Y.)","first-page":"921","volume":"vol. 344","author":"Franklin","year":"2014"},{"key":"10.1016\/j.bbadis.2025.167676_bb0255","series-title":"M1\/M2 Macrophages and their Overlaps - Myth or Reality? Clinical Science (London, England: 1979) 137, 1067\u20131093","author":"Strizova","year":"2023"},{"key":"10.1016\/j.bbadis.2025.167676_bb0260","article-title":"FABP5(+) lipid-loaded macrophages process tumor-derived unsaturated fatty acid signal to suppress T-cell antitumor immunity","author":"Yang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0270","first-page":"1557","article-title":"Spatial single-cell protein landscape reveals vimentin(high) macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma","volume":"5","author":"Qiu","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbadis.2025.167676_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002061","article-title":"Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis","volume":"7","author":"Sitia","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2025.167676_bb0280","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0285","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41419-023-06066-7","article-title":"Harnessing metabolism of hepatic macrophages to aid liver regeneration","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb0290","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0295","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0300","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1084\/jem.20151193","article-title":"Tumor macrophages are pivotal constructors of tumor collagenous matrix","volume":"213","author":"Afik","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0305","doi-asserted-by":"crossref","unstructured":"Wells, R. G. Cellular sources of extracellular matrix in hepatic fibrosis. Clin. Liver Dis. 12, 759\u2013768, viii, doi:https:\/\/doi.org\/10.1016\/j.cld.2008.07.008 (2008).","DOI":"10.1016\/j.cld.2008.07.008"},{"key":"10.1016\/j.bbadis.2025.167676_bb0310","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.cell.2023.03.014","article-title":"Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0315","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2022.03.031","article-title":"Rare ATG7 genetic variants predispose patients to severe fatty liver disease","volume":"77","author":"Baselli","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101891","article-title":"Immune cell - produced ROS and their impact on tumor growth and metastasis","volume":"42","author":"Kennel","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101354","article-title":"Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level","volume":"28","author":"Somasundaram","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0330","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/cr.2013.88","article-title":"ROS sets the stage for macrophage differentiation","volume":"23","author":"Covarrubias","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0335","first-page":"68","article-title":"Elevated FBXL6 activates both wild-type KRAS and mutant KRAS(G12D) and drives HCC tumorigenesis via the ERK\/mTOR\/PRELID2\/ROS axis in mice","volume":"10","author":"Xiong","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0340","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cbi.2007.03.006","article-title":"HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development","volume":"168","author":"Severi","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2025.167676_bb0345","doi-asserted-by":"crossref","unstructured":"Di Bona, M. et al. Micronuclear collapse from oxidative damage. Science (New York, N.Y.) 385, eadj8691, doi:https:\/\/doi.org\/10.1126\/science.adj8691 (2024).","DOI":"10.1126\/science.adj8691"},{"key":"10.1016\/j.bbadis.2025.167676_bb0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5742(00)00059-4","article-title":"Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging","volume":"488","author":"Kawanishi","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.freeradbiomed.2011.09.035","article-title":"Tumor suppressor genes and ROS: complex networks of interactions","volume":"52","author":"Vurusaner","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.niox.2008.04.013","article-title":"Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality","volume":"19","author":"Dunlap","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bbadis.2025.167676_bb0365","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1383-5742(99)00009-5","article-title":"Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition","volume":"443","author":"Halliwell","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0370","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/16.9.2045","article-title":"Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro","volume":"16","author":"Yermilov","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2025.167676_bb0375","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/0008-5472.CAN-05-2884","article-title":"Critical roles for polymerase zeta in cellular tolerance to nitric oxide-induced DNA damage","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0380","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/ars.2011.4414","article-title":"Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy","volume":"16","author":"Gupta","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2025.167676_bb0385","article-title":"Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review","author":"Svobodov\u00e1","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0390","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00281-012-0336-6","article-title":"Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis","volume":"35","author":"Shimizu","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0395","article-title":"Cytokines and hepatocellular carcinoma: biomarkers of a deadly embrace","volume":"13","author":"Pocino","year":"2022","journal-title":"J. Person. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11658-023-00438-9","article-title":"Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance","volume":"28","author":"Hashemi","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbadis.2025.167676_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106493","article-title":"Mammary epithelial cell derived exosomal MiR-221 mediates M1 macrophage polarization via SOCS1\/STATs to promote inflammatory response","volume":"83","author":"Cai","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100324","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP reports: innovation in hepatology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0415","doi-asserted-by":"crossref","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167676_bb0420","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1189\/jlb.0909610","article-title":"TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes\/macrophages","volume":"87","author":"Alciato","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0425","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2567.2011.03511.x","article-title":"Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages","volume":"135","author":"Deng","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0430","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis","volume":"31","author":"Cai","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.167676_bb0435","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1172\/JCI67655","article-title":"MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis","volume":"123","author":"Cook","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167676_bb0440","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","article-title":"A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation","volume":"109","author":"Sather","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.167676_bb0445","doi-asserted-by":"crossref","unstructured":"Seitz, H. M., Camenisch, T. D., Lemke, G., Earp, H. S. & Matsushima, G. K. Macrophages and dendritic cells use different Axl\/Mertk\/Tyro3 receptors in clearance of apoptotic cells. Journal of immunology (Baltimore, Md.: 1950) 178, 5635\u20135642, doi:https:\/\/doi.org\/10.4049\/jimmunol.178.9.5635 (2007).","DOI":"10.4049\/jimmunol.178.9.5635"},{"key":"10.1016\/j.bbadis.2025.167676_bb0450","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jvh.12048","article-title":"DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B","volume":"20","author":"Zhao","year":"2013","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.bbadis.2025.167676_bb0455","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"705\u2013714","key":"10.1016\/j.bbadis.2025.167676_bb0460","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0465","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0470","doi-asserted-by":"crossref","first-page":"G631","DOI":"10.1152\/ajpgi.00185.2007","article-title":"Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis","volume":"293","author":"Son","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0475","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/15353702211061376","article-title":"Wnt signaling in biliary development, proliferation, and fibrosis","volume":"247","author":"Tian","year":"2022","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071545","article-title":"Macrophage phenotypes regulate scar formation and chronic wound healing","volume":"18","author":"Hesketh","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167676_bb0485","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","article-title":"The PDGF system and its antagonists in liver fibrosis","volume":"28","author":"Borkham-Kamphorst","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbadis.2025.167676_bb0490","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1074\/jbc.M115.691519","article-title":"Molecular mechanism responsible for fibronectin-controlled alterations in matrix stiffness in advanced chronic liver Fibrogenesis","volume":"291","author":"Iwasaki","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167676_bb0495","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"Cogliati","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2023.0125","article-title":"Recent advances in the management of hepatocellular carcinoma","volume":"30","author":"Sankar","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0505","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12967-023-04810-3","article-title":"Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy","volume":"22","author":"Xiong","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0510","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.devcel.2020.05.031","article-title":"Matrix rigidity controls epithelial-mesenchymal plasticity and tumor metastasis via a Mechanoresponsive EPHA2\/LYN complex","volume":"54","author":"Fattet","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0515","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13578-022-00856-w","article-title":"New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction","volume":"12","author":"Zhao","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbadis.2025.167676_bb0520","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28468","article-title":"A new HIF-1\u03b1\/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1\/HAF in mice","volume":"63","author":"Koh","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0525","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3390\/ijms11082901","article-title":"Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the \u2018niche\u2019 of endothelial progenitor cells","volume":"11","author":"Yu","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167676_bb0530","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2017.10.037","article-title":"Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship","volume":"413","author":"Netea-Maier","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2025.167676_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166655","article-title":"Normal wound healing and tumor angiogenesis as a game of competitive inhibition","volume":"11","author":"Kareva","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.167676_bb0540","doi-asserted-by":"crossref","unstructured":"Harris, A. L. Hypoxia--a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38\u201347, doi:https:\/\/doi.org\/10.1038\/nrc704 (2002).","DOI":"10.1038\/nrc704"},{"key":"10.1016\/j.bbadis.2025.167676_bb0545","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41388-018-0505-8","article-title":"Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the ca(2+)\/PI3K\/AKT pathway","volume":"38","author":"Dou","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2025.167676_bb0550","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0555","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Cao","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.bbadis.2025.167676_bb0560","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbadis.2025.167676_bb0565","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0570","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0575","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/hepr.12356","article-title":"Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma","volume":"45","author":"Lin","year":"2015","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0580","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/hep.23118","article-title":"Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation","volume":"50","author":"Mazzocca","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0585","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.24485","article-title":"Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts","volume":"54","author":"Mazzocca","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0590","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/0008-5472.CAN-14-1607","article-title":"Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma","volume":"75","author":"Mazzocca","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0595","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mc.23516","article-title":"Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice","volume":"62","author":"Gnocchi","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbadis.2025.167676_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153942","article-title":"Cellular adaptation takes advantage of atavistic regression programs during carcinogenesis","volume":"15","author":"Gnocchi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2025.167676_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043710","article-title":"Metabolism as a new avenue for hepatocellular carcinoma therapy","volume":"24","author":"Gnocchi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167676_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cas.12314","article-title":"Clinical significance of macrophage heterogeneity in human malignant tumors","volume":"105","author":"Komohara","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2025.167676_bb0615","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ccr.2011.11.003","article-title":"IL-10 elicits IFN\u03b3-dependent tumor immune surveillance","volume":"20","author":"Mumm","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0620","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/gutjnl-2014-307671","article-title":"Tim-3 fosters HCC development by enhancing TGF-\u03b2-mediated alternative activation of macrophages","volume":"64","author":"Yan","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2025.167676_bb0625","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0630","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","article-title":"Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer","volume":"40","author":"Kersten","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0635","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.trecan.2023.11.007","article-title":"Metabolic interplay: tumor macrophages and regulatory T cells","volume":"10","author":"Vilbois","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0640","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/ars.2016.6811","article-title":"Macrophage NOS2 in tumor leukocytes","volume":"26","author":"Br\u00fcne","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2025.167676_bb0645","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167676_bb0650","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167676_bb0655","doi-asserted-by":"crossref","unstructured":"Oh, S. A. & Li, M. O. TGF-\u03b2: guardian of T cell function. Journal of immunology (Baltimore, Md.: 1950) 191, 3973\u20133979, doi:https:\/\/doi.org\/10.4049\/jimmunol.1301843 (2013).","DOI":"10.4049\/jimmunol.1301843"},{"key":"10.1016\/j.bbadis.2025.167676_bb0660","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","article-title":"The role of Kupffer cells in hepatitis B and hepatitis C virus infections","volume":"61","author":"Boltjes","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0665","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/hep.30666","article-title":"Sorafenib induces Pyroptosis in macrophages and triggers natural killer cell-mediated cytotoxicity against hepatocellular carcinoma","volume":"70","author":"Hage","year":"2019","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0670","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.27070","article-title":"Blockade of CD47-mediated cathepsin S\/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma","volume":"60","author":"Lee","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0675","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.200708043","article-title":"Inhibition of \u201cself\u201d engulfment through deactivation of myosin-II at the phagocytic synapse between human cells","volume":"180","author":"Tsai","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0680","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2025.167676_bb0685","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell-mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.167676_bb0690","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2025.167676_bb0695","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13045-020-00989-w","article-title":"Targeting the myeloid checkpoint receptor SIRP\u03b1 potentiates innate and adaptive immune responses to promote anti-tumor activity","volume":"13","author":"Kuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0700","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000905","article-title":"CD47\/SIRP\u03b1 blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0705","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2018.08.061","article-title":"LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance","volume":"175","author":"Cunha","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0710","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.29372","article-title":"Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bbadis.2025.167676_bb0715","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-023-01867-y","article-title":"The strategies to cure cancer patients by eradicating cancer stem-like cells","volume":"22","author":"Mai","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0720","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0725","doi-asserted-by":"crossref","first-page":"C1431","DOI":"10.1152\/ajpcell.00508.2023","article-title":"Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits","volume":"325","author":"Gnocchi","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0730","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41419-020-03127-z","article-title":"Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100672","article-title":"High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"JHEP reports: innovation in hepatology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0740","first-page":"253","article-title":"Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway","volume":"41","author":"Xu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbadis.2025.167676_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109905","article-title":"Exosomal miRNAs-mediated macrophage polarization and its potential clinical application","volume":"117","author":"Yu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0750","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb0755","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/thno.87962","article-title":"Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2025.167676_bb0760","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.biopha.2018.09.067","article-title":"PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3\/ERK-dependent activation of Wnt\/\u03b2-catenin signaling pathway","volume":"108","author":"Gao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.167676_bb0765","doi-asserted-by":"crossref","unstructured":"Cai, J. et al. Tumor-Associated Macrophages Derived TGF-\u03b2\u2013Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3\u20134\/Snail Signaling Pathway. Cancer Res. Treat. 51, 252\u2013266, doi:https:\/\/doi.org\/10.4143\/crt.2017.613 (2019).","DOI":"10.4143\/crt.2017.613"},{"key":"10.1016\/j.bbadis.2025.167676_bb0770","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0775","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12935-018-0590-3","article-title":"MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma","volume":"18","author":"Li","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2025.167676_bb0780","first-page":"3","article-title":"Hypoxia-inducible factors in hepatocellular carcinoma (review)","volume":"43","author":"Guo","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2025.167676_bb0785","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","article-title":"Perivascular M2 macrophages stimulate tumor relapse after chemotherapy","volume":"75","author":"Hughes","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0790","doi-asserted-by":"crossref","unstructured":"Murdoch, C., Muthana, M. & Lewis, C. E. Hypoxia regulates macrophage functions in inflammation. Journal of immunology (Baltimore, Md.: 1950) 175, 6257\u20136263, doi:https:\/\/doi.org\/10.4049\/jimmunol.175.10.6257 (2005).","DOI":"10.4049\/jimmunol.175.10.6257"},{"key":"10.1016\/j.bbadis.2025.167676_bb0795","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.019","article-title":"Individualized precision treatment: targeting TAM in HCC","volume":"458","author":"Li","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2025.167676_bb0800","first-page":"73","article-title":"Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages","volume":"40","author":"Zhou","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbadis.2025.167676_bb0805","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","article-title":"Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection","volume":"65","author":"Guiducci","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0810","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1659096","article-title":"Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors","volume":"8","author":"Kapp","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0815","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/cts.13387","article-title":"Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid a analog development","volume":"15","author":"Steeghs","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbadis.2025.167676_bb0820","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0825","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmet.2012.04.023","article-title":"The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism","volume":"15","author":"Haschemi","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.167676_bb0830","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1172\/JCI45862","article-title":"Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice","volume":"121","author":"Lu","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167676_bb0835","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001657","article-title":"Regorafenib enhances antitumor immunity via inhibition of p38 kinase\/Creb1\/Klf4 axis in tumor-associated macrophages","volume":"9","author":"Ou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb0840","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12935-021-02435-4","article-title":"Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment","volume":"22","author":"Chen","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2025.167676_bb0845","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0038-1673621","article-title":"Immunomodulatory effects of current targeted therapies on hepatocellular carcinoma: implication for the future of immunotherapy","volume":"38","author":"Lin","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb0850","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1158\/0008-5472.CAN-18-1229","article-title":"Inhibition of casein kinase 2 disrupts differentiation of myeloid cells in Cancer and enhances the efficacy of immunotherapy in mice","volume":"78","author":"Hashimoto","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0855","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0865","doi-asserted-by":"crossref","unstructured":"Zizzo, G., Hilliard, B. A., Monestier, M. & Cohen, P. L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. Journal of immunology (Baltimore, Md.: 1950) 189, 3508\u20133520, doi:https:\/\/doi.org\/10.4049\/jimmunol.1200662 (2012).","DOI":"10.4049\/jimmunol.1200662"},{"key":"10.1016\/j.bbadis.2025.167676_bb0870","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167676_bb0875","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/0008-5472.CAN-15-0869","article-title":"M-CSF and GM-CSF receptor signaling differentially regulate monocyte maturation and macrophage polarization in the tumor microenvironment","volume":"76","author":"Van Overmeire","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0880","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.7150\/thno.69494","article-title":"Crosstalk between macrophage-derived PGE(2) and tumor UHRF1 drives hepatocellular carcinoma progression","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2025.167676_bb0885","article-title":"Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors","volume":"11","author":"Wesolowski","year":"2019","journal-title":"Therap. Adv. Med. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0890","first-page":"372","article-title":"Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1\/2\/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models","volume":"38","author":"Peng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbadis.2025.167676_bb0895","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-16-0866","article-title":"Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma","volume":"16","author":"Ao","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2025.167676_bb0900","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2025.167676_bb0905","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1470-2045(15)00132-1","article-title":"CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study","volume":"16","author":"Cassier","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0910","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/annonc\/mdz163","article-title":"Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced\/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages","volume":"30","author":"Gomez-Roca","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0915","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2025.167676_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102463","article-title":"Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"56","author":"Hao","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0925","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167676_bb0930","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1158\/0008-5472.CAN-23-3106","article-title":"Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy","volume":"84","author":"Weng","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb0935","doi-asserted-by":"crossref","first-page":"27764","DOI":"10.1021\/acsnano.4c10742","article-title":"Simvastatin-loaded polymeric nanoparticles: targeting inflammatory macrophages for local adipose tissue Browning in obesity treatment","volume":"18","author":"Mohaghegh","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbadis.2025.167676_bb0940","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biomaterials.2016.11.009","article-title":"Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles","volume":"114","author":"Ergen","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2025.167676_bb0945","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biomaterials.2019.03.025","article-title":"Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo","volume":"206","author":"Ergen","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2025.167676_bb0950","doi-asserted-by":"crossref","unstructured":"Kim, B. et al. Securing the Payload, Finding the Cell, and Avoiding the Endosome: Peptide-Targeted, Fusogenic Porous Silicon Nanoparticles for Delivery of siRNA. Advanced materials (Deerfield Beach, Fla.) 31, e1902952, doi:https:\/\/doi.org\/10.1002\/adma.201902952 (2019).","DOI":"10.1002\/adma.201902952"},{"key":"10.1016\/j.bbadis.2025.167676_bb0955","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biomaterials.2018.04.006","article-title":"Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing","volume":"178","author":"Gauthier","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2025.167676_bb0960","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2016.02.011","article-title":"Cellular biodistribution of polymeric nanoparticles in the immune system","volume":"227","author":"Yang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbadis.2025.167676_bb0965","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.bioeng.8.061505.095852","article-title":"Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery","volume":"9","author":"Ferrara","year":"2007","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.bbadis.2025.167676_bb0970","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167676_bb0975","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies. Advanced materials (Deerfield Beach, Fla.) 33, e2007603, doi:https:\/\/doi.org\/10.1002\/adma.202007603 (2021).","DOI":"10.1002\/adma.202007603"},{"key":"10.1016\/j.bbadis.2025.167676_bb0980","article-title":"D-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma","volume":"9, eadg2697","author":"Han","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbadis.2025.167676_bb0985","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jconrel.2023.07.021","article-title":"Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy","volume":"360","author":"Yang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbadis.2025.167676_bb0990","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13045-019-0742-5","article-title":"Immune cell therapy for hepatocellular carcinoma","volume":"12","author":"Mizukoshi","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb0995","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41419-024-06616-7","article-title":"Advances in engineered macrophages: a new frontier in Cancer immunotherapy","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167676_bb1000","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jhep.2024.01.034","article-title":"Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models","volume":"80","author":"Dai","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167676_bb1005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41423-024-01220-3","article-title":"Silencing of SIRP\u03b1 enhances the antitumor efficacy of CAR-M in solid tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb1010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-021-01156-5","article-title":"Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response","volume":"14","author":"Park","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb1015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cellimm.2017.12.007","article-title":"Dynamic plasticity of macrophage functions in diseased liver","volume":"330","author":"Ritz","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bbadis.2025.167676_bb1020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12935-023-02999-3","article-title":"Macrophage\u2019s role in solid tumors: two edges of a sword","volume":"23","author":"Jahandideh","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2025.167676_bb1025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06256-5","article-title":"Reprogramming tumour-associated macrophages to outcompete cancer cells","volume":"619","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167676_bb1030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.24401","article-title":"Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages","volume":"125","author":"Duluc","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2025.167676_bb1035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11864-019-0601-1","article-title":"Systemic therapy for advanced hepatocellular carcinoma in an evolving landscape","volume":"20","author":"Mody","year":"2019","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.bbadis.2025.167676_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107700","article-title":"Targeting the tumor immune microenvironment with \u201cnutraceuticals\u201d: from bench to clinical trials","volume":"219","author":"Masuelli","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2025.167676_bb1045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194875","article-title":"The gut microbiome as a biomarker and therapeutic target in hepatocellular carcinoma","volume":"15","author":"Gok Yavuz","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2025.167676_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127777","article-title":"Microbes in the tumor microenvironment: new additions to break the tumor immunotherapy dilemma","volume":"285","author":"Zhou","year":"2024","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bbadis.2025.167676_bb1055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167676_bb1060","doi-asserted-by":"crossref","first-page":"24854","DOI":"10.1021\/acsnano.3c05627","article-title":"Magnetic resonance imaging Nanoprobe quantifies nitric oxide for evaluating M1\/M2 macrophage polarization and prognosis of Cancer treatments","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbadis.2025.167676_bb1065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2015.06.022","article-title":"Immune repertoire: a potential biomarker and therapeutic for hepatocellular carcinoma","volume":"379","author":"Han","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2025.167676_bb1070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3350\/cmh.2021.0308","article-title":"Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma","volume":"28","author":"Sung","year":"2022","journal-title":"Clin. Mol. Hepatol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:08:01Z","timestamp":1772456881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":214,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0925443925000213"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167676","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167676"}}